Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-31 Clague Laura Chief Financial Officer Grant or award · Performance-based restricted stock units +10,000 10,000
2020-01-31 Dube Eric M Chief Executive Officer Grant or award +35,000 77,500
2020-01-31 Dube Eric M Chief Executive Officer Grant or award · Employee stock option (right to buy) +300,000 300,000
2020-01-31 Dube Eric M Chief Executive Officer Grant or award · Performance-based restricted stock units +35,000 35,000
2020-01-31 Dube Eric M Chief Executive Officer Grant or award · Performance-based restricted stock units +30,000 30,000
2020-01-08 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −750 $15.14 $11K 18,008
2020-01-08 Dube Eric M Chief Executive Officer Sale −3,750 $15.14 $57K 42,500
2020-01-07 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −750 $13.94 $10K 18,758
2020-01-07 Dube Eric M Chief Executive Officer Sale −3,750 $13.94 $52K 46,250
2019-11-29 ASELAGE STEVE Director Sale −5,000 $13.91 $70K 250,966
2019-10-01 Heerma Peter Chief Commercial Officer Grant or award +35,000 35,000
2019-10-01 Heerma Peter Chief Commercial Officer Grant or award · Employee stock option (right to buy) +100,000 100,000
2019-07-31 Rosenberg Noah L. Chief Medical Officer Sale −1,250 $20.07 $25K 13,500
2019-07-30 Rosenberg Noah L. Chief Medical Officer Sale −1,250 $19.82 $25K 14,750
2019-05-16 McFarlane Neil F. Chief Operating Officer Sale −984 $18.71 $18K 26,988
2019-05-16 Clague Laura Chief Financial Officer Sale −1,250 $18.71 $23K 13,500
2019-05-15 McFarlane Neil F. Chief Operating Officer Sale −984 $17.78 $17K 27,972
2019-05-15 Clague Laura Chief Financial Officer Sale −1,250 $17.78 $22K 14,750
2019-05-15 ROTE WILLIAM E. Senior Vice President, R&D Sale −812 $17.76 $14K 18,185
2019-05-15 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −525 $17.71 $9K 19,508

Page 45 of 51 · 1,020 trades